Melanoma Expert Who Tested Immunotherapy on His Own Brain Cancer Dies at 59

Professor Richard Scolyer, the Australian pathologist who led the Melanoma Institute and became Australian of the Year in 2024, died from glioblastoma at 59 in June 2026. He survived nearly two years—double the typical survival span—after becoming the first person to receive immunotherapy for brain cancer before surgery, applying insights from his own melanoma work.